Mankind Pharma

Biocon secures US FDA approval, Glenmark launches cancer generic, Mankind signs licensing agreement

Updated On: 16 Nov 2026 | 10:52 PM IST

Stocks to buy today: Shrikant Chouhan of Kotak Neo has shared a bullish view on two healthcare stocks: Mankind Pharma and Dr Lal Pathlabs.

Updated On: 03 Nov 2026 | 7:43 AM IST

Mankind Pharma share price: Going ahead, improving domestic volumes, rising chronic contribution and sustained export momentum are expected to support growth, say analysts.

Updated On: 27 Oct 2026 | 10:06 AM IST

The drugmaker's revenue rose 17.3 per cent to ₹4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio.

Updated On: 26 Oct 2026 | 5:42 PM IST

Q2FY27 company results: Firms including Mankind Pharma, Dalmia Bharat, APL Apollo Tubes, and Aegis Logistics are also to release their July-September earnings today

Updated On: 26 Oct 2026 | 10:18 AM IST

Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions

Updated On: 15 Oct 2026 | 9:06 PM IST

The top 10 in August included Sun Pharma, Cipla, Abbott, Mankind Pharma, Torrent Pharmaceuticals, Alkem Laboratories, Intas Pharmaceuticals, Lupin, Zydus Lifesciences and Dr Reddy's Laboratories

Updated On: 21 Sep 2026 | 7:20 AM IST

Firm eyes more partnerships with Chinese pharmaceutical companies to expand its in-licensed drug pipeline as it seeks a larger presence in injectable diabetes therapies

Updated On: 20 Aug 2026 | 7:29 PM IST

Brokerages said that Mankind Pharma's Consumer Healthcare growth was muted in Q1, impacted by the discontinuation of discounted cash-and-carry sales.

Updated On: 31 Jul 2026 | 3:07 PM IST

Profit before tax rose 42.4 per cent to ₹769 crore as expenses grew slower than revenue and finance costs declined 35.6 per cent; tax expense more than doubled

Updated On: 30 Jul 2026 | 4:16 PM IST

Stocks to Watch today, May 20, 2026: BPCL, Karnataka Bank, Hindalco, Mankind Pharma, and JSW Energy are some of the key stocks to watch today

Updated On: 20 May 2026 | 8:07 AM IST

Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products

Updated On: 20 May 2026 | 12:10 AM IST

Q4FY26 company results: Firms including Zydus Lifesciences, BASF India, PI Industries, Zee Entertainment, and Bosch Home Comfort India are also to release their January-March earnings today

Updated On: 19 May 2026 | 9:29 AM IST

The acquisition is expected to strengthen Mankind Pharma's presence in the central nervous system (CNS) segment and complement its existing neuro portfolio

Updated On: 18 Mar 2026 | 11:42 AM IST

JM Financial raised concerns around Mankind Pharma's recent BSV acquisition, which was executed at a high valuation and is expected to dilute return on capital

Updated On: 10 Feb 2026 | 12:31 PM IST

Mankind Pharma recorded profit after tax (PAT) of ₹414 crore, up from ₹378 crore in the same quarter last year. Its revenue from operations also grew 11.5 per cent

Updated On: 04 Feb 2026 | 11:11 AM IST

Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies

Updated On: 03 Feb 2026 | 7:05 PM IST

Mankind Pharma has entered a licensing agreement with Actimed Therapeutics to develop and commercialise cachexia treatment products across India and neighbouring South Asian markets

Updated On: 20 Nov 2025 | 6:52 PM IST

Stocks to Watch today, November 7, 2025: From Bharti Airtel, LIC, Bajaj Housing Finance, Lupin, here is a list of stocks that will be in focus today

Updated On: 07 Nov 2025 | 8:33 AM IST

Mankind Pharma's Q2 FY26 profit fell to Rs 520 crore on higher finance and input costs, even as strong domestic and export growth lifted revenue by over 20%.

Updated On: 06 Nov 2025 | 8:38 PM IST